Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccinesBrian P Dolan, Kenneth D Gibbs, Suzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cellsBrian P Dolan, Kenneth D Gibbs, Suzanne Ostrand-RosenbergCancer Immunology Research|May 14, 2014
A soluble form of CD80 enhances antitumor immunity by neutralizing programmed death ligand-1 and simultaneously providing costimulationSamuel T Haile, Lucas A Horn, Suzanne Ostrand-RosenbergFrontiers in Oncology|April 20, 2019
Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of RadiotherapySuzanne Ostrand-Rosenberg, Lucas A Horn, Nicholas G CiavattoneJournal of Leukocyte Biology|February 12, 2016
High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagyKatherine H Parker, Lucas A Horn, Suzanne Ostrand-RosenbergCancer Research|August 3, 2002
Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinomaBeth A Pulaski, Mark J Smyth, Suzanne Ostrand-RosenbergJournal of Immunology (Baltimore, Md. : 1950)|October 5, 2014
The programmed death-1 immune-suppressive pathway: barrier to antitumor immunitySuzanne Ostrand-Rosenberg, Lucas A Horn, Samuel T HaileCancer Immunology, Immunotherapy : CII|March 21, 2015
Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cellsSuzanne Ostrand-Rosenberg, Lucas A Horn, Juan A AlvarezEuropean Journal of Immunology|June 8, 2012
Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4RαPratima Sinha, Katherine H Parker, Lucas Horn, et al.Molecular & Cellular Proteomics : MCP|September 4, 2012
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patientsOlesya Chornoguz, Alexei Gapeev, Michael C O'Neill, et al.Pageof 9